"Lymphoma - Pipeline Review, H2 2012" Now Available at Fast Market Research
Global Markets Direct's, 'Lymphoma - Pipeline Review, H2 2012', provides an overview of the Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lymphoma. 'Lymphoma - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases...
View full press release